CalciMedica, Inc. Current Assets
CalciMedica, Inc. (CALC) had Current Assets of $19.46 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $19.46M.
- 2026-03-31: Assets, Current $8.55M.
- 2025-12-31: Assets, Current $13.53M.
- 2025-09-30: Assets, Current $14.85M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $19.46M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $8.55M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $13.53M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $14.85M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $18.96M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $25.22M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $19.66M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $15.69M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $20.44M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $26.60M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $11.61M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $15.27M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $20.05M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $34.50M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.73M 10-K · filed 2024-03-28 | $39.67M 10-K · filed 2023-03-09 |
| 2022-09-30 | $45.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $51.73M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $58.22M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $67.08M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $74.50M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $76.05M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $88.82M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $99.24M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $95.11M 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $36.27M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |